Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1990 1
1991 5
1992 1
1993 1
1994 1
1995 2
1996 3
1997 2
1998 2
1999 10
2000 13
2001 13
2002 31
2003 22
2004 28
2005 20
2006 32
2007 23
2008 17
2009 13
2010 8
2011 16
2012 7
2013 11
2014 10
2015 8
2016 11
2017 9
2018 5
2019 8
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 12411555

324 results
Results by year
Filters applied: . Clear all
Page 1
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
Witzig TE, Gordon LI, Cabanillas F, Czuczman MS, Emmanouilides C, Joyce R, Pohlman BL, Bartlett NL, Wiseman GA, Padre N, Grillo-López AJ, Multani P, White CA. Witzig TE, et al. J Clin Oncol. 2002 May 15;20(10):2453-63. doi: 10.1200/JCO.2002.11.076. J Clin Oncol. 2002. PMID: 12011122 Clinical Trial.
324 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page